Nordicus Partners (NORDD) S-1/A 27 Nov 23 IPO registration (amended) Financial data

Cover

Cover	3 Months Ended
	Jun. 30, 2023
Entity Addresses [Line Items]
Document Type	S-1/A
Amendment Flag	true
Amendment Description	Amendment No. 3
Entity Registrant Name	NORDICUS PARTNERS CORPORATION
Entity Central Index Key	0001011060
Entity Tax Identification Number	04-3186647
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	3651 Lindell Road
Entity Address, Address Line Two	Suite D565
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89103
City Area Code	(424)
Local Phone Number	256-8560
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	3651 Lindell Road
Entity Address, Address Line Two	Suite D565
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89103
City Area Code	(424)
Local Phone Number	256-8560
Contact Personnel Name	Henrik Rouf

Balance Sheets

Balance Sheets - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Mar. 31, 2022
Current assets:
Cash	$ 32,040	$ 7,149	$ 245,945
Receivable		44,481
Prepaids and other current assets	775	770	3,500
Total current assets	32,815	52,400	249,445
Website	2,639	2,625
Investment in Myson, Inc.	1,750,000
Total Assets	1,785,454	55,025	249,445
Current liabilities:
Accounts payable and accrued expenses	2,094	1,354	43,422
Total current liabilities	23,153	27,367	54,934
Total Liabilities	23,153	27,367	54,934
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Common stock; $0.001 par value; 50,000,000 shares authorized; 10,796,248 and 8,296,248 shares issued; respectively	10,796	8,296	5,681
Treasury stock, 1,534 shares at cost	(30,328)	(30,328)	(30,328)
Common stock to be issued	25,000
Additional paid-in capital	43,994,188	42,246,688	33,944,605
Accumulated other comprehensive income	604	665
Accumulated deficit	(42,237,959)	(42,197,663)	(33,725,447)
Total stockholders’ equity	1,762,301	27,658	194,511
Total liabilities and stockholders’ equity	1,785,454	55,025	249,445
Related Party [Member]
Current liabilities:
Accounts payable – related party	7,173	12,127	11,512
Related party payable	$ 13,886	$ 13,886

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Mar. 31, 2023	Mar. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000	5,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, par value	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000	50,000,000
Common stock, shares issued	10,796,248	8,296,248	5,681,248
Treasury stock, shares	1,534	1,534	1,534

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Officer compensation	$ 27,000
Stock based compensation– related party		5,009,771	$ 8,141,501
Professional fees	19,925	9,004	102,286	119,863
Consulting expense			39,602	105,565
General and administrative	4,664	16,359	196,500	83,743
Total operating expenses	51,589	5,035,134	8,479,889	309,171
Loss from operations	(51,589)	(5,035,134)	(8,479,889)	(309,171)
Other income:
Interest expense			(382)
Interest income	1,913
Other income	9,380		8,055	22,000
Total other income	11,293		7,673	22,000
Loss from operations before provision for income taxes	(40,296)	(5,035,134)	(8,472,216)	(287,171)
Provision for income taxes
Net loss	(40,296)	(5,035,134)	(8,472,216)	(287,171)
Other comprehensive income:
Foreign currency translation adjustment	(61)		665
Comprehensive Loss	$ (40,357)	$ (5,035,134)	$ (8,471,551)	$ (287,171)
Net loss per common share - basic	$ 0	$ (0.89)	$ (1.43)	$ (0.30)
Net loss per common share - diluted	$ 0	$ (0.89)	$ (1.43)	$ (0.30)
Weighted average shared - basic	8,570,973	5,681,248	5,938,851	944,651
Weighted average shared - diluted	8,570,973	5,681,248	5,938,851	944,651

Statements of Changes in Stockh

Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Common Stock To Be Issued [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Mar. 31, 2021	$ 567	$ 33,549,719	$ (33,438,276)	$ (30,328)			$ 81,682
Beginning balance, shares at Mar. 31, 2021	566,773
Common stock issued to an investor	$ 5,114	394,886					400,000
Common stock issued to an investor, shares	5,114,475
Net loss			(287,171)				(287,171)
Ending balance, value at Mar. 31, 2022	$ 5,681	33,944,605	(33,725,447)	(30,328)			194,511
Ending balance, shares at Mar. 31, 2022	5,681,248
Net loss			(5,035,134)				(5,035,134)
Stock-based compensation - fair value of warrants– related party		5,009,771					5,009,771
Ending balance, value at Jun. 30, 2022	$ 5,681	38,954,376	(38,760,581)	(30,328)			169,148
Ending balance, shares at Jun. 30, 2022	5,681,248
Beginning balance, value at Mar. 31, 2022	$ 5,681	33,944,605	(33,725,447)	(30,328)			194,511
Beginning balance, shares at Mar. 31, 2022	5,681,248
Net loss			(8,472,216)			665	(8,471,551)
Stock-based compensation - fair value of warrants– related party		8,141,501					8,141,501
Shares issued for acquisition	$ 2,500	45,697					48,197
Shares issued for acquisition, shares	2,500,000
Exercise of warrants	$ 115	114,885					115,000
Exercise of warrants, shares	115,000
Ending balance, value at Mar. 31, 2023	$ 8,296	42,246,688	(42,197,663)	(30,328)		665	27,658
Ending balance, shares at Mar. 31, 2023	8,296,248
Net loss			(40,296)			(61)	(40,357)
Exercise of warrants					25,000		25,000
Shares issued for stock investment	$ 2,500	1,747,500					1,750,000
Shares issued for stock investment, shares	2,500,000
Ending balance, value at Jun. 30, 2023	$ 10,796	$ 43,994,188	$ (42,237,959)	$ (30,328)	$ 25,000	$ 604	$ 1,762,301
Ending balance, shares at Jun. 30, 2023	10,796,248

Statements of Cash Flows

Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (40,296)	$ (5,035,134)	$ (8,472,216)	$ (287,171)
Adjustments to reconcile net loss to net cash flows used in operating activities
Stock-based compensation – related party		5,009,771	8,141,501
Changes in assets and liabilities:
Prepaid expenses	(19)	1,750	3,500	(3,500)
Receivables	44,481
Accounts payable – related party	(4,954)
Accounts payable and accrued expenses	740	(36,363)	(41,132)	8,290
Net cash used in operating activities	(48)	(59,976)	(368,347)	(282,381)
Cash flows from financing activities:
Proceeds from note payable			40,000
Repayment of note payable			(40,000)
Proceeds from exercise of warrants	25,000		115,000
Cash advance - related party			13,886
Issuance of common stock to an investor				400,000
Net cash provided by financing activities	25,000		128,886	400,000
Net change in cash	24,952	(59,976)	(239,461)	117,619
Effect of exchange rate on cash	(61)		665
Cash at beginning of period	7,149	245,945	245,945	128,326
Cash at end of period	32,040	185,969	7,149	245,945
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid
Supplemental disclosure of non-cash activity:
Common stock issued for shares of Myson, Inc.	$ 1,750,000

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Accounting Policies [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Nordicus Partners Corporation (the “Company” “Nordicus”) was founded in 1993 as a subsidiary of PolyMedica Corporation. On January 31, 2020, we completed the sale of substantially all of our assets (the “Asset Sale”) for a total purchase price of $ 7,250,000 As a result of the Asset Sale, we ceased operating as a developer, manufacturer, marketer and seller of advanced polymers. Subsequent to the Closing Date, we became engaged in efforts to identify either an (i) operating company to acquire or merge with through an equity-based exchange transaction or (ii) investor interested in purchasing a majority interest in our common stock, whereby either transaction would likely result in a change in control. On October 12, 2021, we entered into a Stock Purchase Agreement (the “SPA”) with Reddington Partners LLC, a California limited liability company (“Reddington”) providing for the purchase of a total of 5,114,475 90 400,000 On March 3, 2020, we filed a Certificate of Amendment to the Company’s Certificate of Incorporation, which amendment was unanimously approved by our Board of Directors, to change our name AdvanSource Biomaterials Corporation to EKIMAS Corporation. Pursuant to the SPA, the Company effectuated a 1-for 50 reverse stock split 422,725 4,691,750 5,114,475 90 On February 23, 2023, the Company entered into a Contribution Agreement with Nordicus Partners A/S, a Danish stock corporation, GK Partners ApS (“GK Partners”), Henrik Rouf and Life Science Power House ApS (“LSPH, GK Partners, Rouf and LSPH are collectively referred to herein as the “Sellers”). Pursuant to the Contribution Agreement, the Sellers contributed, transferred, assigned and conveyed to the Company all right, title and interest in and to one hundred percent ( 100 %) of the issued and outstanding capital stock of Nordicus Partners A/S for an aggregate of 2,500,000 shares of the Company’s common stock. As a result of this transaction, Nordicus Partners A/S became a 100 % wholly owned subsidiary of the Company. On May 17, 2023, the Company changed its name to Nordicus Partners Corporation and its ticker symbol to NORD. On June 9, 2023, Tom Glaesner Larsen resigned from the Company’s board of directors, and the remaining board members appointed Henrik Keller as his replacement.	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Nordicus Partners Corporation (the “Company”) was founded in 1993 as a subsidiary of PolyMedica Corporation. On January 31, 2020, we completed the sale of substantially all of our assets (the “Asset Sale”) for a total purchase price of $ 7,250,000 As a result of the Asset Sale, we ceased operating as a developer, manufacturer, marketer and seller of advanced polymers. Subsequent to the Closing Date, we became engaged in efforts to identify either an (i) operating company to acquire or merge with through an equity-based exchange transaction or (ii) investor interested in purchasing a majority interest in our common stock, whereby either transaction would likely result in a change in control. On October 12, 2021, we entered into a Stock Purchase Agreement (the “SPA”) with Reddington Partners LLC, a California limited liability company (“Reddington”) providing for the purchase of a total of 5,114,475 90 400,000 On March 3, 2020, we filed a Certificate of Amendment to the Company’s Certificate of Incorporation, which amendment was unanimously approved by our Board of Directors, to change our name AdvanSource Biomaterials Corporation to EKIMAS Corporation. Pursuant to the SPA, the Company effectuated a 1-for 50 reverse stock split 422,725 4,691,750 5,114,475 90 On February 23, 2023, we entered into a Contribution Agreement with Nordicus Partners A/S, a Danish stock corporation, GK Partners ApS (“GK Partners”), Henrik Rouf and Life Science Power House ApS (“LSPH, GK Partners, Rouf and LSPH are collectively referred to herein as the “Sellers”). Pursuant to the Contribution Agreement, the Sellers contributed, transferred, assigned and conveyed to us all right, title and interest in and to one hundred percent ( 100 %) of the issued and outstanding capital stock of Nordicus Partners A/S for an aggregate of 2,500,000 shares of our common stock. As a result of this transaction, Nordicus Partners A/S became our 100 % wholly owned subsidiary. On May 17, 2023, we changed our name to Nordicus Partners Corporation and our ticker symbol to NORD.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The Company’s unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending June 30, 2023, and not necessarily indicative of the results to be expected for the full year ending March 31, 2024. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2023. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill. Concentration of Credit Risk We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no Principles of Consolidation The accompanying consolidated financial statements, includes the accounts of the Company and its wholly owned subsidiary, Nordicus Partners A/S. All significant intercompany transactions have been eliminated in consolidation. Translation Adjustment The accounts of the Company’s subsidiary are maintained in Danish krone. According to the Codification, all assets and liabilities were translated at the current exchange rate at respective balance sheets dates, members’ capital are translated at the historical rates and income statement items are translated at the average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with the Comprehensive Income Topic of the Codification (ASC 220), as a component of Stockholders’ equity. Transaction gains and losses are reflected in the income statement. Comprehensive Income The Company uses SFAS 130 “Reporting Comprehensive Income” (ASC Topic 220). Comprehensive income is comprised of net income and all changes to the statements of Stockholders’ equity, except changes in paid-in capital and distributions to shareholders. Comprehensive income is included in net loss and foreign currency translation adjustments. Stock-based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. Net Income (Loss) Per Common Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. As of June 30, 2023 and 2022, there were 6,610,000 5,860,000 Recently Issued Accounting Pronouncements The Company has implemented all new applicable accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill. Concentration of Credit Risk We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no Principles of Consolidation The accompanying consolidated financial statements for the year ended March 31, 2023, includes the accounts of the Company and its wholly owned subsidiary, Nordicus Partners A/S. All significant intercompany transactions have been eliminated in consolidation. Translation Adjustment The accounts of the Company’s subsidiary are maintained in Danish krone. According to the Codification, all assets and liabilities were translated at the current exchange rate at respective balance sheets dates, members’ capital are translated at the historical rates and income statement items are translated at the average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with the Comprehensive Income Topic of the Codification (ASC 220), as a component of Stockholders’ equity. Transaction gains and losses are reflected in the income statement. Comprehensive Income The Company uses SFAS 130 “Reporting Comprehensive Income” (ASC Topic 220). Comprehensive income is comprised of net income and all changes to the statements of Stockholders’ equity, except changes in paid-in capital and distributions to shareholders. Comprehensive income is included in net loss and foreign currency translation adjustments. Stock-based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximate the fair value of such instruments based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangements on March 31, 2023 and 2022. Net Income (Loss) Per Common Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. As of March 31, 2023, there are 6,635,000 no Income Taxes Income taxes are provided for the tax effects of the transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to tax net operating loss carryforwards. The deferred tax assets and liabilities represent the future tax return consequences of these differences, which will either be taxable or deductible when assets and liabilities are recovered or settled, as well as operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established against deferred tax assets when in the judgment of management, it is more likely than not that such deferred tax assets will not become available. Because the judgment about the level of future taxable income is dependent to a great extent on matters that may, at least in part, be beyond the Company’s control, it is at least reasonably possible that management’s judgment about the need for a valuation allowance for deferred taxes could change in the near term. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of March 31, 2023, and 2022, no liability for unrecognized tax benefits was required to be reported. Recently Issued Accounting Pronouncements The Company has implemented all new applicable accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

GOING CONCERN

GOING CONCERN	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 3 - GOING CONCERN The Company’s financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has not yet generated any revenue and has incurred losses since inception resulting in an accumulated deficit of $ 42,237,959 The ability to continue as a going concern is dependent upon the Company’s recent acquisition, its generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from third parties and/or private placement of common stock. The financial statements of the Company do not include any adjustments that may result from the outcome of these uncertainties.	NOTE 3 - GOING CONCERN The Company’s financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has not yet generated any revenue and has incurred losses since inception resulting in an accumulated deficit of $ 42,197,663 The ability to continue as a going concern is dependent upon the Company’s recent acquisition, its generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from third parties and/or private placement of common stock. The financial statements of the Company do not include any adjustments that may result from the outcome of these uncertainties.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 4 - RELATED PARTY TRANSACTIONS Mr. Tom Glasner Larsen is an affiliate of GK Partners and was a member of our board of directors from February 23, 2023, until his voluntary retirement on June 9, 2023. He was also a beneficial owner of a controlling interest in Nordicus Partners A/S until its acquisition by us on February 23, 2023. On April 11, 2022, effective April 1, 2022, we issued to GK Partners, for financial services, a warrant to immediately purchase up to 6,000,000 1.00 115,000 1.00 115,000 25,000 25,000 25,000 25,000 30,000 30,000 On February 23, 2023, pursuant to the Contribution Agreement by and among the Company, Nordicus Partners A/S, GK Partners ApS (“GK Partners”), Henrik Rouf and Life Science Power House ApS (“LSPH”), we issued 2,500,000 On June 20, 2023, the Company and GK Partners ApS (the “Seller”) entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which the Seller sold to the Company 5,000,000 2,500,000 Mr. Bennett Yankowitz, our chief financial officer and a director, was affiliated with legal counsel who provided us with general legal services (the “Affiliate”). We recorded legal fees to the Affiliate of $ 10,924 11,557 7,713 2,217 As of March 31, 2023, the Company had a receivable of $ 44,481 On April 17, 2023, our Board of Directors approved an employment agreement for our chief executive officer, Henrik Rouf, and a consulting agreement for our chief financial officer, Bennett J. Yankowitz. Mr. Rouf’s employment agreement provides for a base salary of $ 72,000 one year Mr. Yankowitz’s consulting agreement provides for a base salary of $ 36,000 one year	NOTE 4 - RELATED PARTY TRANSACTIONS Mr. Michael Adams, our former chief executive officer, was a non-employee consultant and holder of less than 1.0 0 12,000 0 2,000 Mr. Tom Glasner Larsen is an affiliate of GK Partners and was a member of our board of directors from February 23, 2023, until his voluntary retirement on June 9, 2023. He was also a beneficial owner of a controlling interest in Nordicus Partners A/S until its acquisition by us on February 23, 2023. On April 11, 2022, effective April 1, 2022, we issued to GK Partners, for financial services, a warrant to immediately purchase up to 6,000,000 1.00 115,000 1.00 115,000 On February 23, 2023, pursuant to the Contribution Agreement by and among the Company, Nordicus Partners A/S, GK Partners ApS (“GK Partners”), Henrik Rouf and Life Science Power House ApS (“LSPH”), we issued 2,500,000 shares of the common stock (Note 1). On June 20, 2023, the Company and GK Partners ApS (the “Seller”) entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which the Seller sold to the Company 5,000,000 2,500,000 Mr. Bennett Yankowitz, our chief financial officer and a director, was affiliated with legal counsel who provided us with general legal services (the “Affiliate”). We recorded legal fees paid to the Affiliate of $ 35,415 11,453 12,217 11,512 On November 28, 2022, we issued Mr. Yankowitz a warrant to purchase 250,000 1.00 As of March 31, 2023, the Company has a receivable of $44,481

NOTE PAYABLE

NOTE PAYABLE	12 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
NOTE PAYABLE	NOTE 5 – NOTE PAYABLE On October 14, 2022, the Company issued a Demand Promissory Note (“Note”) to GK Partners ApS for which it received $ 40,000 3 June 30, 2023 40,000 382

PREFERRED STOCK

PREFERRED STOCK	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Equity [Abstract]
PREFERRED STOCK	NOTE 5 - PREFERRED STOCK Preferred Stock We have authorized 5,000,000 0.001 500,000 500,000	NOTE 6 - PREFERRED STOCK Preferred Stock We have authorized 5,000,000 0.001 500,000

COMMON STOCK TRANSACTIONS

COMMON STOCK TRANSACTIONS	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Equity [Abstract]
COMMON STOCK TRANSACTIONS	NOTE 6 - COMMON STOCK TRANSACTIONS On June 26, 2023, GK Partners exercised a portion of its warrant for 25,000 1.00 25,000 25,000 25,000 30,000 30,000 On June 20, 2023, the Company and GK Partners ApS entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which the Seller sold to the Company 5,000,000 2,500,000 1,750,000 0.70 1.00	NOTE 7 - COMMON STOCK TRANSACTIONS On October 12, 2021, we entered into a Stock Purchase Agreement (the “SPA”) with Reddington Partners LLC, a California limited liability company (“Reddington”) providing for the purchase of a total of 5,114,475 400,000 The sale of the first tranche of 21,136,250 4,434,240 25,570,490 51.8 Pursuant to the SPA, the Company effectuated a 1-for 50 reverse stock split 422,725 4,691,750 5,114,475 90 The cumulative purchase price for both tranches of shares of our common stock was $ 400,000 200,000 100,000 100,000 200,000 100,000 200,000 Our Board of Directors declared a cash distribution to stockholders pursuant to the terms and conditions of the SPA. The cash distribution of approximately $ 141,000 0.25 On February 14, 2023, GK Partners exercised a portion of its warrant for 115,000 1.00 115,000 On February 23, 2023, pursuant to the Contribution Agreement by and among the Company, Nordicus, GK Partners, Henrik Rouf and Life Science Power House ApS (“LSPH”), the Company issued 2,500,000 shares of the common stock (Note 1).

WARRANTS

WARRANTS	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Warrants
WARRANTS	NOTE 7 - WARRANTS On April 11, 2022, effective April 1, 2022, we issued to GK Partners ApS, for financial services, a warrant to immediately purchase up to 6,000,000 1.00 December 31, 2023 1.00 1.22 1.75 699.79 0.0 2.44 7,316,971 On November 28, 2022, we issued 1) to David Volpe a warrant to purchase 500,000 250,000 1.00 December 31, 2027 1.00 1.12 5 206 0.0 3.88 825,000 SCHEDULE OF WARRANT ACTIVITIES Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contract Term Intrinsic Value Outstanding, March 31, 2023 6,635,000 $ 1.00 1.21 $ — Issued — $ — — Cancelled — $ — — Exercised (25,000 ) $ — — Outstanding, June 30, 2023 6,610,000 $ 1.00 0.96 $ —	NOTE 8 - WARRANTS On April 11, 2022, effective April 1, 2022, we issued to GK Partners ApS, for financial services, a warrant to immediately purchase up to 6,000,000 1.00 December 31, 2023 1.00 1.22 1.75 699.79 0.0 2.44 7,316,971 On November 28, 2022, we issued 1) to David Volpe a warrant to purchase 500,000 250,000 1.00 December 31, 2027 1.00 1.12 5 206 0.0 3.88 825,000 SCHEDULE OF WARRANT ACTIVITIES Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contract Term Intrinsic Value Outstanding, March 31, 2022 — — — - Issued 6,750,000 $ 1.00 2.13 Cancelled — $ — — Exercised (115,000 ) $ — — Outstanding, March 31, 2023 6,635,000 $ 1.00 1.21 $ —

INCOME TAX

INCOME TAX	12 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAX	NOTE 9 – INCOME TAX Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has evaluated Staff Accounting Bulletin No. 118 regarding the impact of the decreased tax rates of the Tax Cuts & Jobs Act. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The U.S. federal income tax rate of 21 Reconciliation between our effective tax rate and the United States statutory rate is as follows: SCHEDULE OF RECONCILIATION OF EFFECTIVE TAX RATE For the Year Ended March 31, 2023 For the Year Ended March 31, 2022 Expected federal tax rate 21.0 % 21.0 % State income taxes, net of federal tax benefit 6.3 % 6.3 % Non-deductible expenses 0.0 % 0.0 % Effect of net operating loss true-up 0.0 % 0.0 % Utilization of net operating losses (27.3 )% (27.3 )% Effective tax rate 0.0 % 0.0 % Significant components of our deferred tax assets and deferred tax liabilities consist of the following: SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSETS AND DEFERRED TAX LIABILITIES (in thousands) March 31, 2023 March 31, 2022 Deferred Tax Assets: Net operating loss carryforwards $ 2,313,000 $ 3,183 Valuation allowance (2,313,000 ) (3,183 ) Net deferred tax assets $ — $ — At March 31, 2023, the Company had net operating loss carry forwards of approximately $ 35,057,000 No Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for Federal Income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for years before 2016.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8 - SUBSEQUENT EVENTS In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements except as follows: On July 26, 2023, GK Partners exercised a portion of its warrant for an additional 25,000 1.00 25,000	NOTE 10 - SUBSEQUENT EVENTS In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements. On June 9, 2023, Tom Glaesner Larsen resigned from the Company’s board of directors, and the remaining board members appointed Henrik Keller as his replacement. On June 20, 2023, the Company and GK Partners ApS entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which the Seller sold to the Company 5,000,000 2,500,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending June 30, 2023, and not necessarily indicative of the results to be expected for the full year ending March 31, 2024. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2023.	Basis of Presentation The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.
Concentration of Credit Risk	Concentration of Credit Risk We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.	Concentration of Credit Risk We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.
Cash Equivalents	Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no	Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements, includes the accounts of the Company and its wholly owned subsidiary, Nordicus Partners A/S. All significant intercompany transactions have been eliminated in consolidation.	Principles of Consolidation The accompanying consolidated financial statements for the year ended March 31, 2023, includes the accounts of the Company and its wholly owned subsidiary, Nordicus Partners A/S. All significant intercompany transactions have been eliminated in consolidation.
Translation Adjustment	Translation Adjustment The accounts of the Company’s subsidiary are maintained in Danish krone. According to the Codification, all assets and liabilities were translated at the current exchange rate at respective balance sheets dates, members’ capital are translated at the historical rates and income statement items are translated at the average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with the Comprehensive Income Topic of the Codification (ASC 220), as a component of Stockholders’ equity. Transaction gains and losses are reflected in the income statement.	Translation Adjustment The accounts of the Company’s subsidiary are maintained in Danish krone. According to the Codification, all assets and liabilities were translated at the current exchange rate at respective balance sheets dates, members’ capital are translated at the historical rates and income statement items are translated at the average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with the Comprehensive Income Topic of the Codification (ASC 220), as a component of Stockholders’ equity. Transaction gains and losses are reflected in the income statement.
Comprehensive Income	Comprehensive Income The Company uses SFAS 130 “Reporting Comprehensive Income” (ASC Topic 220). Comprehensive income is comprised of net income and all changes to the statements of Stockholders’ equity, except changes in paid-in capital and distributions to shareholders. Comprehensive income is included in net loss and foreign currency translation adjustments.	Comprehensive Income The Company uses SFAS 130 “Reporting Comprehensive Income” (ASC Topic 220). Comprehensive income is comprised of net income and all changes to the statements of Stockholders’ equity, except changes in paid-in capital and distributions to shareholders. Comprehensive income is included in net loss and foreign currency translation adjustments.
Stock-based Compensation	Stock-based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.	Stock-based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.
Fair Value of Financial Instruments		Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximate the fair value of such instruments based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangements on March 31, 2023 and 2022.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. As of June 30, 2023 and 2022, there were 6,610,000 5,860,000	Net Income (Loss) Per Common Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. As of March 31, 2023, there are 6,635,000 no
Income Taxes		Income Taxes Income taxes are provided for the tax effects of the transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to tax net operating loss carryforwards. The deferred tax assets and liabilities represent the future tax return consequences of these differences, which will either be taxable or deductible when assets and liabilities are recovered or settled, as well as operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established against deferred tax assets when in the judgment of management, it is more likely than not that such deferred tax assets will not become available. Because the judgment about the level of future taxable income is dependent to a great extent on matters that may, at least in part, be beyond the Company’s control, it is at least reasonably possible that management’s judgment about the need for a valuation allowance for deferred taxes could change in the near term. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of March 31, 2023, and 2022, no liability for unrecognized tax benefits was required to be reported.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company has implemented all new applicable accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.	Recently Issued Accounting Pronouncements The Company has implemented all new applicable accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

WARRANTS (Tables)

WARRANTS (Tables)	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Warrants
SCHEDULE OF WARRANT ACTIVITIES	SCHEDULE OF WARRANT ACTIVITIES Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contract Term Intrinsic Value Outstanding, March 31, 2023 6,635,000 $ 1.00 1.21 $ — Issued — $ — — Cancelled — $ — — Exercised (25,000 ) $ — — Outstanding, June 30, 2023 6,610,000 $ 1.00 0.96 $ —	SCHEDULE OF WARRANT ACTIVITIES Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contract Term Intrinsic Value Outstanding, March 31, 2022 — — — - Issued 6,750,000 $ 1.00 2.13 Cancelled — $ — — Exercised (115,000 ) $ — — Outstanding, March 31, 2023 6,635,000 $ 1.00 1.21 $ —

INCOME TAX (Tables)

INCOME TAX (Tables)	12 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
SCHEDULE OF RECONCILIATION OF EFFECTIVE TAX RATE	Reconciliation between our effective tax rate and the United States statutory rate is as follows: SCHEDULE OF RECONCILIATION OF EFFECTIVE TAX RATE For the Year Ended March 31, 2023 For the Year Ended March 31, 2022 Expected federal tax rate 21.0 % 21.0 % State income taxes, net of federal tax benefit 6.3 % 6.3 % Non-deductible expenses 0.0 % 0.0 % Effect of net operating loss true-up 0.0 % 0.0 % Utilization of net operating losses (27.3 )% (27.3 )% Effective tax rate 0.0 % 0.0 %
SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSETS AND DEFERRED TAX LIABILITIES	Significant components of our deferred tax assets and deferred tax liabilities consist of the following: SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSETS AND DEFERRED TAX LIABILITIES (in thousands) March 31, 2023 March 31, 2022 Deferred Tax Assets: Net operating loss carryforwards $ 2,313,000 $ 3,183 Valuation allowance (2,313,000 ) (3,183 ) Net deferred tax assets $ — $ —

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) - USD ($)						3 Months Ended
	Feb. 23, 2023	Mar. 15, 2022	Mar. 11, 2022	Oct. 12, 2021	Jan. 31, 2020	Jun. 30, 2023
Total cash consideration						$ 1,750,000
Contribution Agreement [Member]
Stock issued during period, shares, new issues	2,500,000
Percentage of outstanding common stock	100%
Contribution Agreement [Member] | Nordicus Partners A/S [Member]
Subsidiary, Ownership Percentage, Parent	100%
Reddington Partners LLC [Member] | Stock Purchase Agreement [Member]
Stock issued during period, shares, new issues				5,114,475
Percentage of outstanding common stock				90%
Total cash consideration				$ 400,000
Reverse stock split			1-for 50 reverse stock split
Reddington Partners LLC [Member] | Stock Purchase Agreement [Member] | First Closing [Member]
Stock issued during period, shares, new issues			422,725
Reddington Partners LLC [Member] | Stock Purchase Agreement [Member] | Second Closing [Member]
Stock issued during period, shares, new issues		4,691,750
Asset Purchase Agreement [Member]
Purchase price of asset					$ 7,250,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022
Accounting Policies [Abstract]
Cash equivalents	$ 0		$ 0	$ 0
Antidilutive securities	6,610,000	5,860,000	6,635,000	0

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 42,237,959	$ 42,197,663	$ 33,725,447

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)

3 Months Ended

12 Months Ended

Aug. 24, 2023

Jul. 26, 2023

Jun. 26, 2023

Jun. 20, 2023

Apr. 17, 2023

Feb. 23, 2023

Feb. 14, 2023

Jun. 30, 2023

Jun. 30, 2022

Mar. 31, 2023

Mar. 31, 2022

Nov. 28, 2022

Apr. 11, 2022

Related Party Transaction [Line Items]

Consulting fees

$ 19,925

$ 9,004

$ 102,286

$ 119,863

Total proceeds

1,750,000

Receivable

44,481

GK Partners [Member]

Related Party Transaction [Line Items]

Total proceeds

$ 25,000

$ 1,750,000

$ 115,000

Stock Issued During Period, Shares, New Issues

2,500,000

GK Partners [Member] | Restricted Stock [Member]

Related Party Transaction [Line Items]

Shares issued

2,500,000

GK Partners [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Related Party Transaction [Line Items]

Shares issued

2,500,000

Myson Inc [Member] | Restricted Stock [Member]

Related Party Transaction [Line Items]

Shares issued

5,000,000

Myson Inc [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Related Party Transaction [Line Items]

Shares issued

5,000,000

Common Stock [Member]

Related Party Transaction [Line Items]

Total proceeds

$ 2,500

Stock Issued During Period, Shares, New Issues

2,500,000

Common Stock [Member] | GK Partners [Member]

Related Party Transaction [Line Items]

Warrant to purchase shares

6,000,000

Exercise price per share

$ 1

Warrant [Member]

Related Party Transaction [Line Items]

Warrant to purchase shares

115,000

Exercise price per share

$ 1

$ 1

Warrant [Member] | GK Partners [Member]

Related Party Transaction [Line Items]

Warrant to purchase shares

25,000

115,000

6,000,000

Exercise price per share

$ 1

$ 1

$ 1

$ 1

Warrant [Member] | GK Partners [Member] | Subsequent Event [Member]

Related Party Transaction [Line Items]

Warrant to purchase shares

30,000

25,000

Exercise price per share

$ 1

Total proceeds

$ 30,000

$ 25,000

Mr.Michael Adams [Member]

Related Party Transaction [Line Items]

Consulting fees

0

12,000

Reimburse for office expense and car allowance

$ 0

2,000

Mr.Michael Adams [Member] | Maximum [Member]

Related Party Transaction [Line Items]

Percentage of outstanding common stock

1%

Mr Bennett Yankowitz [Member]

Related Party Transaction [Line Items]

Legal fees

$ 10,924

$ 11,557

$ 35,415

11,453

Due to related party

12,217

$ 11,512

Due to related party

$ 7,713

2,217

Mr Yankowitz [Member]

Related Party Transaction [Line Items]

Salary payment

$ 36,000

Agreement term

1 year

Mr Yankowitz [Member] | Common Stock [Member]

Related Party Transaction [Line Items]

Warrant to purchase shares

250,000

Exercise price per share

$ 1

GK Partners [Member]

Related Party Transaction [Line Items]

Receivable

$ 44,481

Mr Rouf [Member]

Related Party Transaction [Line Items]

Salary payment

$ 72,000

Agreement term

1 year

NOTE PAYABLE (Details Narrative

NOTE PAYABLE (Details Narrative) - USD ($)			3 Months Ended		12 Months Ended
	Feb. 16, 2023	Oct. 14, 2022	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022
Repayments of notes					$ 40,000
Interest paid
GK Partners [Member]
Notes payable		$ 40,000
Notes interest rate		3%
Debt maturity date		Jun. 30, 2023
Repayments of notes	$ 40,000
Interest paid	$ 382

PREFERRED STOCK (Details Narrat

PREFERRED STOCK (Details Narrative) - $ / shares	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Mar. 31, 2022
Class of Stock [Line Items]
Preferred stock shares authorized	5,000,000	5,000,000	5,000,000
Preferred stock, par value	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares issued and redeemed	500,000	500,000
Series A Junior Participating Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares authorized	500,000

COMMON STOCK TRANSACTIONS (Deta

COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)

3 Months Ended

12 Months Ended

Aug. 24, 2023

Jul. 26, 2023

Jun. 26, 2023

Jun. 20, 2023

Feb. 23, 2023

Feb. 14, 2023

Sep. 22, 2022

Mar. 15, 2022

Mar. 11, 2022

Oct. 12, 2021

Jun. 30, 2023

Mar. 31, 2023

Mar. 31, 2022

Nov. 28, 2022

Apr. 11, 2022

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment

$ 1,750,000

Proceeds from issuance of stock

$ 400,000

Proceeds from related party

$ 13,886

Cash distribution

$ 141,000

Share price per share

$ 0.25

Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant to purchase shares

115,000

Exercise price per share

$ 1

$ 1

Reddington Partners LLC [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment, shares

21,136,250

Reddington Partners LLC [Member] | Stock Purchase Agreement [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment, shares

5,114,475

Shares issued for stock investment

$ 400,000

Percentage of outstanding common stock

90%

Reverse stock split

1-for 50 reverse stock split

Reddington Partners LLC [Member] | Stock Purchase Agreement [Member] | First Closing [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment, shares

422,725

Proceeds from issuance of stock

$ 200,000

Accrued and unpaid liabilities

100,000

Working capital

100,000

Escrow deposit

200,000

Reddington Partners LLC [Member] | Stock Purchase Agreement [Member] | Second Closing [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment, shares

4,691,750

Accrued and unpaid liabilities

100,000

Proceeds from related party

$ 200,000

Reddington Partners LLC [Member] | Voting Agreement [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment, shares

4,434,240

Investment Owned, Balance, Shares

25,570,490

Percentage of outstanding common stock

51.80%

GK Partners [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment, shares

2,500,000

Shares issued for stock investment

$ 25,000

$ 1,750,000

$ 115,000

Share price per share

$ 0.70

GK Partners [Member] | Restricted Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued

2,500,000

GK Partners [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued

2,500,000

GK Partners [Member] | Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant to purchase shares

25,000

115,000

6,000,000

Exercise price per share

$ 1

$ 1

$ 1

$ 1

GK Partners [Member] | Warrant [Member] | Subsequent Event [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued for stock investment

$ 30,000

$ 25,000

Warrant to purchase shares

30,000

25,000

Exercise price per share

$ 1

Myson Inc [Member] | Restricted Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued

5,000,000

Myson Inc [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued

5,000,000

SCHEDULE OF WARRANT ACTIVITIES

SCHEDULE OF WARRANT ACTIVITIES (Details) - Warrant [Member] - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023
Number of Warrants, Beginning balance	6,635,000
Weighted Average Exercise Price, Beginning balance	$ 1
Intrinsic Value, Beginning balance
Number of Warrants, Issued		6,750,000
Weighted Average Exercise Issued		$ 1
Weighted Average Remaining Contractual term,Issued		2 years 1 month 17 days
Warrants Outstanding, Cancelled
Number of Warrants, Exercised		(115,000)
Number of Warrants, Ending balance		6,635,000
Weighted Average Exercise Price, Ending balance		$ 1
Weighted Average Remaining Contractual term,Outstanding		1 year 2 months 15 days
Intrinsic Value, Ending balances
Number of Warrants, Beginning balance	6,635,000
Weighted Average Exercise Price, Beginning balance	$ 1
Weighted Average Remaining Contractual term,Outstanding	11 months 15 days	1 year 2 months 15 days
Intrinsic Value, Beginning balance
Number of Warrants, Issued
Warrants Outstanding, Cancelled
Number of Warrants, Exercised	(25,000)
Number of Warrants, Ending balance	6,610,000	6,635,000
Weighted Average Exercise Price, Ending balance	$ 1	$ 1
Intrinsic Value, Ending balances

WARRANTS (Details Narrative)

WARRANTS (Details Narrative)			3 Months Ended		12 Months Ended
	Nov. 28, 2022 $ / shares shares	Apr. 11, 2022 $ / shares shares	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Jun. 26, 2023 $ / shares shares	Jun. 20, 2023 $ / shares	Feb. 14, 2023 $ / shares shares	Sep. 22, 2022 $ / shares
Price per share										$ 0.25
Stock based compensation | $				$ 5,009,771	$ 8,141,501
Total stock based compensation | $					825,000
Measurement Input, Exercise Price [Member]
Warrant measurement input	1
Measurement Input, Share Price [Member]
Price per share	$ 1.12
Measurement Input, Expected Term [Member]
Expected term	5 years
Measurement Input, Price Volatility [Member]
Warrant measurement input	206
Measurement Input, Expected Dividend Rate [Member]
Warrant measurement input	0
Measurement Input, Risk Free Interest Rate [Member]
Warrant measurement input	3.88
GK Partners [Member]
Price per share								$ 0.70
Stock based compensation | $					$ 7,316,971
GK Partners [Member] | Measurement Input, Exercise Price [Member]
Warrant measurement input		1
GK Partners [Member] | Measurement Input, Share Price [Member]
Price per share		$ 1.22
GK Partners [Member] | Measurement Input, Expected Term [Member]
Expected term		1 year 9 months
GK Partners [Member] | Measurement Input, Price Volatility [Member]
Warrant measurement input		699.79
GK Partners [Member] | Measurement Input, Expected Dividend Rate [Member]
Warrant measurement input		0
GK Partners [Member] | Measurement Input, Risk Free Interest Rate [Member]
Warrant measurement input		2.44
Warrant [Member]
Warrant to purchase shares | shares									115,000
Exercise price per share	$ 1								$ 1
Exercise price per share	Dec. 31, 2027	Dec. 31, 2023
Warrant [Member] | David Volpe [Member]
Warrant to purchase shares | shares	500,000
Warrant [Member] | Bennett J. Yankowitz [Member]
Warrant to purchase shares | shares	250,000
Warrant [Member] | GK Partners [Member]
Warrant to purchase shares | shares		6,000,000					25,000		115,000
Exercise price per share		$ 1					$ 1	$ 1	$ 1

SCHEDULE OF RECONCILIATION OF E

SCHEDULE OF RECONCILIATION OF EFFECTIVE TAX RATE (Details)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Expected federal tax rate	21%	21%
State income taxes, net of federal tax benefit	6.30%	6.30%
Non-deductible expenses	0%	0%
Effect of net operating loss true-up	0%	0%
Utilization of net operating losses	(27.30%)	(27.30%)
Effective tax rate	0%	0%

SCHEDULE OF SIGNIFICANT COMPONE

SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSETS AND DEFERRED TAX LIABILITIES (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Deferred Tax Assets:
Net operating loss carryforwards	$ 2,313,000	$ 3,183
Valuation allowance	(2,313,000)	(3,183)
Net deferred tax assets

INCOME TAX (Details Narrative)

INCOME TAX (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022
Operating Loss Carryforwards [Line Items]
Expected federal tax rate			21%	21%
Tax benefit
Domestic Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards			$ 35,057

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jul. 26, 2023	Jun. 20, 2023	Aug. 24, 2023	Jun. 26, 2023	Feb. 14, 2023	Nov. 28, 2022	Apr. 11, 2022
Warrant [Member]
Subsequent Event [Line Items]
Warrant to purchase shares					115,000
Exercise price per share					$ 1	$ 1
Myson Inc [Member] | Restricted Stock [Member]
Subsequent Event [Line Items]
Shares issued		5,000,000
Myson Inc [Member] | Subsequent Event [Member] | Restricted Stock [Member]
Subsequent Event [Line Items]
Shares issued		5,000,000
GK Partners [Member] | Warrant [Member]
Subsequent Event [Line Items]
Warrant to purchase shares				25,000	115,000		6,000,000
Exercise price per share		$ 1		$ 1	$ 1		$ 1
GK Partners [Member] | Restricted Stock [Member]
Subsequent Event [Line Items]
Shares issued		2,500,000
GK Partners [Member] | Subsequent Event [Member] | Warrant [Member]
Subsequent Event [Line Items]
Warrant to purchase shares	25,000		30,000
Exercise price per share	$ 1
Proceeds from warrants	$ 25,000
GK Partners [Member] | Subsequent Event [Member] | Restricted Stock [Member]
Subsequent Event [Line Items]
Shares issued		2,500,000